D-892-2013 Class III Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-892-2013 was initiated by American Health Packaging on Feb 4, 2013 and is designated Class III. Reason for recall: Failed Stability Specifications; out of specification results at the 9 month stability time point for color, dissolution and related compounds. The recall status is terminated (terminated Aug 28, 2013). Affected quantity: 389 cartons.

Recall details

Product Type
Drugs
Report Date
Aug 21, 2013
Initiation Date
Feb 4, 2013
Termination Date
Aug 28, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
389 cartons

Product description

buPROPion Hydrochloride Extended Release Tablets, USP 100 mg, 100 count carton, 10 blister cards of 10 individually blistered and labeled tablets, Rx only, Actavis South Atlantic LLC, Packaged and Distributed by: American Health Packaging, Columbus, OH --- NDC 68084-470-01

Reason for recall

Failed Stability Specifications; out of specification results at the 9 month stability time point for color, dissolution and related compounds.

Distribution pattern

Nationwide

Code information

The following codes are affects by the recall: Lot #114500, Exipration Date 08/2013, repackaging date 12/04/2011.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-892-2013
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-892-2013. Report a data issue: hello@regdatalab.com.